File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/00005344-198406002-00017
- Scopus: eid_2-s2.0-0021173895
- PMID: 6206351
- WOS: WOS:A1984SX70200017
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Serotonin and arterial vessels
Title | Serotonin and arterial vessels |
---|---|
Authors | |
Keywords | Adrenergic neurotransmission Endothelium-dependent relaxation Serotonergic receptors Serotonergic transmission Vascular smooth muscle |
Issue Date | 1984 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ |
Citation | Journal Of Cardiovascular Pharmacology, 1984, v. 6 SUPPL. 2, p. S421-S428 How to Cite? |
Abstract | The vasoconstrictor effects of serotonin can be explained by (a) activation of serotonergic receptors on vascular smooth muscle, (b) activation, directly or indirectly, of postjunctional α-adrenoceptors, and (c) amplification of the response to other vasoactive agonists. Vasoconstrictor responses to serotonin may play a role in the etiology of vasospasm and in the maintenance of the augmented peripheral resistance in arterial hypertension. The vasodilator effects of serotonin can be caused by (a) inhibiting vascular smooth muscle directly, (b) releasing other inhibitory substances, such as vasoactive intestinal polypeptide, (c) inhibiting adrenergic neurotransmission, and (d) triggering of endothelium-dependent relaxations. |
Persistent Identifier | http://hdl.handle.net/10722/170728 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.610 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vanhoutte, PM | en_US |
dc.contributor.author | Cohen, RA | en_US |
dc.contributor.author | Van Nueten, JM | en_US |
dc.date.accessioned | 2012-10-30T06:10:37Z | - |
dc.date.available | 2012-10-30T06:10:37Z | - |
dc.date.issued | 1984 | en_US |
dc.identifier.citation | Journal Of Cardiovascular Pharmacology, 1984, v. 6 SUPPL. 2, p. S421-S428 | en_US |
dc.identifier.issn | 0160-2446 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170728 | - |
dc.description.abstract | The vasoconstrictor effects of serotonin can be explained by (a) activation of serotonergic receptors on vascular smooth muscle, (b) activation, directly or indirectly, of postjunctional α-adrenoceptors, and (c) amplification of the response to other vasoactive agonists. Vasoconstrictor responses to serotonin may play a role in the etiology of vasospasm and in the maintenance of the augmented peripheral resistance in arterial hypertension. The vasodilator effects of serotonin can be caused by (a) inhibiting vascular smooth muscle directly, (b) releasing other inhibitory substances, such as vasoactive intestinal polypeptide, (c) inhibiting adrenergic neurotransmission, and (d) triggering of endothelium-dependent relaxations. | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ | en_US |
dc.relation.ispartof | Journal of Cardiovascular Pharmacology | en_US |
dc.subject | Adrenergic neurotransmission | - |
dc.subject | Endothelium-dependent relaxation | - |
dc.subject | Serotonergic receptors | - |
dc.subject | Serotonergic transmission | - |
dc.subject | Vascular smooth muscle | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Arteries - Physiology | en_US |
dc.subject.mesh | Coronary Vessels - Physiology | en_US |
dc.subject.mesh | Endothelium - Cytology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Muscle Contraction - Drug Effects | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Drug Effects | en_US |
dc.subject.mesh | Platelet Aggregation - Drug Effects | en_US |
dc.subject.mesh | Serotonin - Pharmacology - Physiology | en_US |
dc.subject.mesh | Vasoconstriction - Drug Effects | en_US |
dc.subject.mesh | Vasodilation - Drug Effects | en_US |
dc.title | Serotonin and arterial vessels | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1097/00005344-198406002-00017 | - |
dc.identifier.pmid | 6206351 | - |
dc.identifier.scopus | eid_2-s2.0-0021173895 | en_US |
dc.identifier.volume | 6 | en_US |
dc.identifier.issue | SUPPL. 2 | en_US |
dc.identifier.spage | S421 | en_US |
dc.identifier.epage | S428 | en_US |
dc.identifier.isi | WOS:A1984SX70200017 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.scopusauthorid | Cohen, RA=35562815800 | en_US |
dc.identifier.scopusauthorid | Van Nueten, JM=7005700327 | en_US |
dc.identifier.issnl | 0160-2446 | - |